These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Capurro MI; Xu P; Shi W; Li F; Jia A; Filmus J Dev Cell; 2008 May; 14(5):700-11. PubMed ID: 18477453 [TBL] [Abstract][Full Text] [Related]
3. The role of glypican-3 in the regulation of body size and cancer. Filmus J; Capurro M Cell Cycle; 2008 Sep; 7(18):2787-90. PubMed ID: 18787398 [TBL] [Abstract][Full Text] [Related]
4. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Paine-Saunders S; Viviano BL; Zupicich J; Skarnes WC; Saunders S Dev Biol; 2000 Sep; 225(1):179-87. PubMed ID: 10964473 [TBL] [Abstract][Full Text] [Related]
5. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072 [TBL] [Abstract][Full Text] [Related]
6. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714 [TBL] [Abstract][Full Text] [Related]
8. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Pellegrini M; Pilia G; Pantano S; Lucchini F; Uda M; Fumi M; Cao A; Schlessinger D; Forabosco A Dev Dyn; 1998 Dec; 213(4):431-9. PubMed ID: 9853964 [TBL] [Abstract][Full Text] [Related]
9. GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Li M; Shuman C; Fei YL; Cutiongco E; Bender HA; Stevens C; Wilkins-Haug L; Day-Salvatore D; Yong SL; Geraghty MT; Squire J; Weksberg R Am J Med Genet; 2001 Aug; 102(2):161-8. PubMed ID: 11477610 [TBL] [Abstract][Full Text] [Related]
10. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896 [TBL] [Abstract][Full Text] [Related]
11. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Davoodi J; Kelly J; Gendron NH; MacKenzie AE Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790 [TBL] [Abstract][Full Text] [Related]
12. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790 [TBL] [Abstract][Full Text] [Related]
13. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling. Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487 [TBL] [Abstract][Full Text] [Related]
14. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713 [TBL] [Abstract][Full Text] [Related]
15. Glypican 3 and glypican 4 are juxtaposed in Xq26.1. Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407 [TBL] [Abstract][Full Text] [Related]
16. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. Khan S; Blackburn M; Mao DL; Huber R; Schlessinger D; Fant M Histol Histopathol; 2001 Jan; 16(1):71-8. PubMed ID: 11193214 [TBL] [Abstract][Full Text] [Related]
17. SIMPSON-GOLABI-BEHMEL syndrome type 1: How placental immunohistochemistry can rapidly Predict the diagnosis. Fiandrino G; Arossa A; Ghirardello S; Kalantari S; Rossi C; Bonasoni MP; Cesari S; Rizzuti T; Giorgio E; Bassanese F; Scatigno AL; Meroni A; Melito C; Feltri M; Longo S; Figar TA; Andorno A; Gelli MC; Bertozzi M; Spinillo A; Riccipetitoni G; Valente EM; Paulli M; Sirchia F Placenta; 2022 Aug; 126():119-124. PubMed ID: 35796063 [TBL] [Abstract][Full Text] [Related]
18. Overgrowth of a mouse model of Simpson-Golabi-Behmel syndrome is partly mediated by Indian hedgehog. Capurro MI; Li F; Filmus J EMBO Rep; 2009 Aug; 10(8):901-7. PubMed ID: 19590577 [TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Liu B; Paranjpe S; Bowen WC; Bell AW; Luo JH; Yu YP; Mars WM; Michalopoulos GK Am J Pathol; 2009 Aug; 175(2):717-24. PubMed ID: 19574424 [TBL] [Abstract][Full Text] [Related]
20. Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations. Yano S; Baskin B; Bagheri A; Watanabe Y; Moseley K; Nishimura A; Matsumoto N; Ray PN Clin Genet; 2011 Nov; 80(5):466-71. PubMed ID: 20950395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]